Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Lécuyer D, Nardacci R, Tannous D, Gutierrez-Mateyron E, Deva Nathan A, Subra F, Di Primio C, Quaranta P, Petit V, Richetta C, Mostefa-Kara A, Del Nonno F, Falasca L, Marlin R, Maisonnasse P, Delahousse J, Pascaud J, Deprez E, Naigeon M, Chaput N, Paci A, Saada V, Ghez D, Mariette X, Costa M, Pistello M, Allouch A, Delelis O, Piacentini M, Le Grand R, Perfettini JL. Lécuyer D, et al. Among authors: paci a. Front Immunol. 2023 Oct 18;14:1270081. doi: 10.3389/fimmu.2023.1270081. eCollection 2023. Front Immunol. 2023. PMID: 37920468 Free PMC article.
Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network.
Faron M, Naman A, Delahousse J, Hescot S, Hadoux J, Castinetti F, Drui D, Renoult-Pierre P, Libe R, Lamartina L, Leboulleux S, Al-Ghuzlan A, Lombès M, Paci A, Baudin E; For Endocan-Comete Network. Faron M, et al. Among authors: paci a. J Endocrinol Invest. 2024 Aug 22. doi: 10.1007/s40618-024-02439-7. Online ahead of print. J Endocrinol Invest. 2024. PMID: 39172357
Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.
Delahousse J, Wagner AD, Borchmann S, Adjei AA, Haanen J, Burgers F, Letsch A, Quaas A, Oertelt-Prigione S, Özdemir BC, Verhoeven RHA, Della Pasqua O, Paci A, Mir O. Delahousse J, et al. Among authors: paci a. ESMO Open. 2024 Dec;9(12):104002. doi: 10.1016/j.esmoop.2024.104002. Epub 2024 Dec 10. ESMO Open. 2024. PMID: 39662226 Free article.
Tyrosine kinase inhibitors in cancers: Treatment optimization - Part I.
Combarel D, Dousset L, Bouchet S, Ferrer F, Tetu P, Lebbe C, Ciccolini J, Meyer N, Paci A. Combarel D, et al. Among authors: paci a. Crit Rev Oncol Hematol. 2024 Jul;199:104384. doi: 10.1016/j.critrevonc.2024.104384. Epub 2024 May 16. Crit Rev Oncol Hematol. 2024. PMID: 38762217 Review.
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Danhardt L, Wiedemann A, Michel G, Dalle JH, Rialland F, Renard C, Jubert C, Maertens J, Sirvent A, Buchbinder N, Devalck C, Brichard B, Paillard C, Nguyen S, Paci A, Combarel D, Castelle M, Pagliuca S, Pochon C. Danhardt L, et al. Among authors: paci a. EJHaem. 2024 Nov 26;5(6):1295-1300. doi: 10.1002/jha2.1056. eCollection 2024 Dec. EJHaem. 2024. PMID: 39691249 Free PMC article.
Tyrosine kinase inhibitors in cancers: Treatment optimization - Part II.
Ferrer F, Tetu P, Dousset L, Lebbe C, Ciccolini J, Combarel D, Meyer N, Paci A, Bouchet S. Ferrer F, et al. Among authors: paci a. Crit Rev Oncol Hematol. 2024 Aug;200:104385. doi: 10.1016/j.critrevonc.2024.104385. Epub 2024 May 27. Crit Rev Oncol Hematol. 2024. PMID: 38810843 Review.
326 results